OCX   $0.4  1.06% Market Closed

Oncocyte Corp
Total Cash 9.26M
totalCashPerShare 0.692
EBITDA -20.22M
Total Debt 3.67M
quickRatio 1.298
currentRatio 1.385
Total Revenue 1.02M
debtToEquity 16.152
Revenue/Share 0.109
ROA -0.16666001
ROE -1.01763
grossProfits
freeCashflow -5.22M
operatingCashflow -18.00M
earningsGrowth
revenueGrowth -0.775
grossMargins 0.30694
ebitdaMargins 0.0
operatingMargins -54.45192
profitMargins 0.0
enterpriseValue 32.38M
forwardPE -1.6416184
floatShares 5.43M
sharesOutstanding 16.84M
sharesShort 189.33K
sharesShortPriorMonth 182.84K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.51%
Short Ratio help_outline 7.46%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 1.698
Price To Book help_outline 1.67
earningsQuarterlyGrowth
netIncomeToCommon -36.80M
trailingEps -4.16%
forwardEps -1.73%
enterpriseToEbitda -1.60
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 27
lastUpdated Nov. 7, 2024, 4:57 a.m.